Sam – Page 291 – biolegacy

Ad Comm Gives Thumbs Up to Gene Therapy for Inherited Eye Disease

Post author:Sam
Post published:October 12, 2017
Post category:Drug Industry Daily

An FDA advisory committee unanimously endorsed Spark Therapeutics’ gene therapy for vision loss. Source: Drug Industry Daily

<b>Spruce Biosciences</b> Provides Corporate Update On Series A Venture Financing, Leadership Team And Lead Clinical Program

Post author:Sam
Post published:October 11, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

AcelRx Stopped Cold: FDA Rejects NDA for Pain Drug Dsuvia (ARX-04)

Post author:Sam
Post published:October 11, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"AcelRx Stopped Cold: FDA Rejects NDA for Pain Drug Dsuvia (ARX-04)" ALT"AcelRx Stopped Cold: FDA Rejects NDA for Pain Drug Dsuvia (ARX-04)"October 12, 2017By Alex Keown, BioSpace.com Breaking…

Harvard???s Ph.D., A Leader In Alzheimer???s Disease Genetics, Joins Cerevance???s Advisory Board

Post author:Sam
Post published:October 11, 2017
Post category:BioPharma

BOSTON--(BUSINESS WIRE)--Cerevance, a drug discovery and development company focused on brain diseases, today announced that Rudolph Tanzi, Ph.D., has joined the company as a senior-level scientific advisor. Dr. Tanzi is…

Ardelyx Shares Soared After Positive Phase III Results for Tenapanor

Post author:Sam
Post published:October 11, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-stock-positive.jpg" NAME"Ardelyx Shares Soared After Positive Phase III Results for Tenapanor" ALT"Ardelyx Shares Soared After Positive Phase III Results for Tenapanor"October 12, 2017By Alex Keown, BioSpace.com Breaking... Source: BioSpace

Anika Therapeutics To Issue Third-Quarter 2017 Financial Results And Business Highlights On Wednesday, October 25

Post author:Sam
Post published:October 11, 2017
Post category:BioPharma

BEDFORD, Mass.--(BUSINESS WIRE)--Anika ... Source: BioSpace

Merck & Co. Scraps Experimental Cholesterol Drug Anacetrapib

Post author:Sam
Post published:October 11, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-merck.jpg" NAME"Merck Scraps Experimental Cholesterol Drug Anacetrapib" ALT"Merck Scraps Experimental Cholesterol Drug Anacetrapib"October 12, 2017By Mark Terry, BioSpace.com Breaking News StaffKenilworth, NJ... Source: BioSpace

WAVE Life Sciences To Present At

Post author:Sam
Post published:October 11, 2017
Post category:BioPharma

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, today announced that Paul Bolno, M.D., MBA, President and…

The Best Career Advice from Axovant's CEO

Post author:Sam
Post published:October 11, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-axovant-david-hung.jpg" NAME"Heres the Best Career Advice from Axovant's CEO" ALT"Heres the Best Career Advice from Axovant's CEO"October 12, 2017By Mark Terry, BioSpace.com Breaking News StaffWant career advice... Source: BioSpace

Johnson & Johnson Innovation, Releases Impact Report

Post author:Sam
Post published:October 11, 2017
Post category:BioPharma

SAN DIEGO, Oct. 12, 2017 /PRNewswire/ --<img src"https://mma.prnewswire.com/media/582279/Johnson_and_Johnson_Innovation_LLC___JLABS.jpg" title"Johnson & Johnson Innovation, JLABS (PRNewsFoto/Johnson & Johnson Innovation, LL)" alt... Source: BioSpace